Abstract
In Switzerland an official consensus on indication guidelines for neuroleptic relapse prevention has not been formulated and/or published. Long-term treatment (longer than 1 year) with neuroleptics is indicated mainly for patients with chronic schizophrenia (2 years without symptom-free intervals). For some patients with a subacute course (1/2 year without a symptom-free interval) long-term treatment may be indicated as well.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Woggon, B. (1991). Switzerland: Neuroleptic Relapse Prevention. In: Kissling, W. (eds) Guidelines for Neuroleptic Relapse Prevention in Schizophrenia. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-86922-8_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-86922-8_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-53985-8
Online ISBN: 978-3-642-86922-8
eBook Packages: Springer Book Archive